Terms: = Testicular cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Treatment
4 results:
1. The New Molecular Landscape of Cushing's Disease.
Sbiera S; Deutschbein T; Weigand I; Reincke M; Fassnacht M; Allolio B
Trends Endocrinol Metab; 2015 Oct; 26(10):573-583. PubMed ID: 26412158
[TBL] [Abstract] [Full Text] [Related]
2. Novobiocin and additional inhibitors of the hsp90 C-terminal nucleotide-binding pocket.
Donnelly A; Blagg BS
Curr Med Chem; 2008; 15(26):2702-17. PubMed ID: 18991631
[TBL] [Abstract] [Full Text] [Related]
3. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones hsp90/Cdc37.
Nony P; Gaude H; Rossel M; Fournier L; Rouault JP; Billaud M
Oncogene; 2003 Dec; 22(57):9165-75. PubMed ID: 14668798
[TBL] [Abstract] [Full Text] [Related]
4. 17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells.
Fumo G; Akin C; Metcalfe DD; Neckers L
Blood; 2004 Feb; 103(3):1078-84. PubMed ID: 14551138
[TBL] [Abstract] [Full Text] [Related]
